DE69821930D1 - Hgf polypeptide und deren therapeutische verwendungen - Google Patents

Hgf polypeptide und deren therapeutische verwendungen

Info

Publication number
DE69821930D1
DE69821930D1 DE69821930T DE69821930T DE69821930D1 DE 69821930 D1 DE69821930 D1 DE 69821930D1 DE 69821930 T DE69821930 T DE 69821930T DE 69821930 T DE69821930 T DE 69821930T DE 69821930 D1 DE69821930 D1 DE 69821930D1
Authority
DE
Germany
Prior art keywords
therapeutic use
hgf
hgf polypeptides
polypeptides
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69821930T
Other languages
English (en)
Other versions
DE69821930T2 (de
Inventor
Ermanno Gherardi
Walter Birchmeier
Guido Hartmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of DE69821930D1 publication Critical patent/DE69821930D1/de
Application granted granted Critical
Publication of DE69821930T2 publication Critical patent/DE69821930T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
DE69821930T 1997-05-10 1998-05-07 Hgf polypeptide und deren therapeutische verwendungen Expired - Fee Related DE69821930T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9709453.6A GB9709453D0 (en) 1997-05-10 1997-05-10 Polypedtides and their use in therapy
GB9709453 1997-05-10
PCT/GB1998/001318 WO1998051798A1 (en) 1997-05-10 1998-05-07 Hgf polypeptides and their use in therapy

Publications (2)

Publication Number Publication Date
DE69821930D1 true DE69821930D1 (de) 2004-04-01
DE69821930T2 DE69821930T2 (de) 2005-01-05

Family

ID=10812072

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69821930T Expired - Fee Related DE69821930T2 (de) 1997-05-10 1998-05-07 Hgf polypeptide und deren therapeutische verwendungen

Country Status (10)

Country Link
EP (1) EP0981620B1 (de)
JP (1) JP2001526540A (de)
AT (1) ATE260341T1 (de)
AU (1) AU7343898A (de)
CA (1) CA2289720A1 (de)
DE (1) DE69821930T2 (de)
DK (1) DK0981620T3 (de)
ES (1) ES2219888T3 (de)
GB (1) GB9709453D0 (de)
WO (1) WO1998051798A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2356701C (en) * 1999-10-29 2011-02-15 Ryuichi Morishita Gene therapy for diabetic ischemic disease
EP2219656A2 (de) 2007-11-09 2010-08-25 New York Medical College Verfahren zur reparatur und/oder regeneration von geschädigtem myokard mit varianten des hepatozyten-wachstumsfaktors
CN109535243B (zh) * 2019-01-07 2019-09-24 北京诺思兰德生物技术股份有限公司 人肝细胞生长因子突变体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2118012A1 (en) * 1992-05-18 1993-11-25 Paul J. Godowski Hepatocyte growth factor variants
AU698221B2 (en) * 1994-12-27 1998-10-29 Atlas Pharmaceuticals Inc. TCF mutant

Also Published As

Publication number Publication date
ES2219888T3 (es) 2004-12-01
GB9709453D0 (en) 1997-07-02
AU7343898A (en) 1998-12-08
EP0981620B1 (de) 2004-02-25
ATE260341T1 (de) 2004-03-15
JP2001526540A (ja) 2001-12-18
WO1998051798A1 (en) 1998-11-19
DE69821930T2 (de) 2005-01-05
DK0981620T3 (da) 2004-06-28
EP0981620A1 (de) 2000-03-01
CA2289720A1 (en) 1998-11-19

Similar Documents

Publication Publication Date Title
NZ336865A (en) Use of a therapeutic agent containing a neurotrophic factor for treatment of diabetes and hyperlipemia
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
EP0349235A3 (en) Niacin-containing composition and its therapeutic use
DK0833612T3 (da) Ny farmaceutisk sammensætning med bedøvende virkning
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
DE3880212D1 (de) Pharmazeutische zusammensetzung zur hautabsorption und hautabsorptionsverstaerkung von medikamenten.
EP0177342A3 (de) Orale Formulierungen therapeutischer Proteine
DE3879811D1 (de) Pharmazeutische zusammensetzung und ihre verwendung.
EP0249307A3 (en) Collapsible truss unit for use in combination with other like units for the construction of frameworks
DK241190D0 (da) Polypeptider stabiliseret med kovalente hydrogenbindingserstatninger
DE69821930D1 (de) Hgf polypeptide und deren therapeutische verwendungen
DE69232716T2 (de) Peptide mit thrombospondin-ähnlicher Aktivität und ihre therapeutische Verwendung
BR9507451A (pt) Composição farmacêutica uso de uma quantidade de (i) um antígeno padronizado em conjunto com uma quantidade de (ii) um polipeptídeo e produto contendo uma quantidade de (i) um antígeno padronizado em conjunto com uma quantidade de (ii) um polipeptídeo
DE69312319D1 (de) Tachyquinin antagonisten, ihre herstellung und ihre verwendung in pharmazeutischen formulierungen
IL112075A0 (en) Recombinant human thymopoietin proteins, their preparation and their medicinal use
NO971508D0 (no) Analoger sv sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet
DE68927854D1 (de) Insulinomimetrische eigenschaften und insulin-rezeptor-bindestellen-peptide
ATE277948T1 (de) Bpc peptid salze mit organ-schützender aktivität, deren herstellung und therapeutische verwendung
DE69637411D1 (de) Antikörper gegen den menschlichen gastrinfreisetzenden Peptidvorläufer und deren Verwendung
HU9402329D0 (en) New coniugates of pharmaceutically active polypeptides with enhanced and prolongued activity and pharmaceutical compositions containing them
DE69121210D1 (de) Therapeutische verwendung des fibroblastenwachstumsfaktors
DK513589A (da) Human epitelcelleomdannende vaekstfaktor og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende vaekstfaktoren
DE69310002D1 (de) Stabilisierte biologisch aktive Polypeptide und deren Verwendung
BR9301722A (pt) Cabine terapêutica pressurizada com oxigênio medicinal
IT8748222A0 (it) Tropina da solo o in combinazione uso di un medicamento a base di un con l'ormone follicolo-stimolante fattore di rilascio della somatonel trattamento della sterilita

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee